Insight to Combat Post COVID-19 Mortality: Complications and their Biomarkers

被引:0
|
作者
Srivastava, Rajnish [1 ]
Patel, Pankaj Singh [2 ]
Dev, Suresh Kumar [3 ]
Pradhan, Joohee [2 ]
Panchawat, Sunita [2 ]
机构
[1] Moradabad Educ Trust Grp Inst, Fac Pharm, Moradabad, Uttar Pradesh, India
[2] Mohanlal Sukhadia Univ, Dept Pharmaceut Sci, Udaipur, Rajasthan, India
[3] Pacific Acad Higher Educ & Res Univ, Pacific Coll Pharm, Udaipur, Rajasthan, India
关键词
COVID-19; molecular pathogenesis; biomarker; pulmonary mucormycosis; pulmonary fibrosis; pulmonary aspergillosis; INVASIVE PULMONARY ASPERGILLOSIS; PATHOLOGICAL FINDINGS; CYTOKINE STORM;
D O I
10.2174/1566524022666220812111830
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background COVID-19 is a severe acute respiratory syndrome that has become a prominent source of morbidity and mortality around the world. With millions infected globally by the COVID-19 epidemic, long-term care for COVID-19 survivors has become a global concern. As a result, research into the long-term pulmonary and extrapulmonary consequences and complications of COVID is absolutely necessary. Objectives In an attempt to better understand and mitigate post recovery mortality, early detection of the post recovery complication might prevent the severity of the complication and can be recovered. As per cases reported, post covid extrapulmonary complications were more than pulmonary complications. However, the post covid pulmonary complications were found to be more lethal and nonrecoverable in most of the cases than extrapulmonary complications. Methods The present review is an attempt to reveal the role and importance of biomarkers associated with critical post covid pulmonary complications. COVID-19 is associated with post-covid pulmonary fibrosis, pulmonary endothelial dysfunction, pulmonary aspergillosis, pulmonary mucormycosis, biomarkers and WHO, as keywords were used to retrieve updated information. PubMed, and Google Scholar were used as search engines for this. Results There must be a better knowledge of the post-COVID-19 pulmonary problems in terms of systemic pathophysiological results to create multidisciplinary clinics to address both long-term symptoms and potential long-term consequences. This can be achieved by revealing the molecular pathogenesis that can be validated by certain biomarkers and various diagnostic techniques. Accordingly, the clinical program can be designed to treat and effectively manage the post covid pulmonary complications in early-stage to prevent mortality. Conclusion In order to deal with the specific logistical problems given by pandemic circumstances, effective interdisciplinary collaboration models draw on experiences learned during the early phases of the pandemic.
引用
收藏
页码:712 / 725
页数:14
相关论文
共 50 条
  • [41] Oxidative Biomarkers Associated with the Pulmonary Manifestation of Post-COVID-19 Complications
    Siekacz, Kamil
    Kumor-Kisielewska, Anna
    Milkowska-Dymanowska, Joanna
    Pietrusinska, Malgorzata
    Bartczak, Krystian
    Majewski, Sebastian
    Stanczyk, Adam
    Piotrowski, Wojciech J. J.
    Bialas, Adam J. J.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [42] Surviving COVID-19 and multiple complications post total laryngectomy
    Singh, Arpana
    Bhardwaj, Abhishek
    Ravichandran, Nivedhan
    Malhotra, Manu
    BMJ CASE REPORTS, 2021, 14 (07)
  • [43] The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications
    Mercade-Besora, Nuria
    Li, Xintong
    Kolde, Raivo
    Trinh, Nhung T. H.
    Sanchez-Santos, Maria T.
    Man, Wai Yi
    Roel, Elena
    Reyes, Carlen
    Delmestri, Antonella
    Nordeng, Hedvig M. E.
    Uuskula, Anneli
    Duarte-Salles, Talita
    Prats, Clara
    Prieto-Alhambra, Daniel
    Jodicke, Annika M.
    Catala, Marti
    HEART, 2024, 110 (09) : 635 - 643
  • [44] COVID-19 Vaccination: Safeguarding Against Post-COVID Cardiovascular Complications
    Kow, Chia Siang
    Ramachandram, Dinesh Sangarran
    Hasan, Syed Shahzad
    Thiruchelvam, Kaeshaelya
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (01) : 274 - 275
  • [45] Effect of COVID-19 vaccines on post-COVID cardiac and thromboembolic complications
    Mercade Besora, Nuria
    Prieto-Alhambra, Daniel
    Roel, Elena
    Delmestri, Antonella
    Prats, Clara
    Jodicke, Annika M.
    Catala Sabate, Marti
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 625 - 626
  • [47] Nursing to combat the COVID-19 pandemic
    da Silva, Francisca Valda
    REVISTA BRASILEIRA DE ENFERMAGEM, 2020, 73
  • [48] Vaccinate to combat COVID-19 in China
    Chen, Ruishan
    Guo, Xiaona
    Zhu, Annah
    SCIENCE, 2022, 377 (6603) : 271 - 271
  • [49] Senolytics combat COVID-19 in aging
    Xu Zhang
    Masayoshi Suda
    Yi Zhu
    Nature Aging, 2023, 3 : 762 - 763
  • [50] CPPIT Action to Combat the COVID-19
    Qi Li
    China's Foreign Trade, 2020, (01) : 8 - 11